Medical Research Project

Cardiomyopathy in pregnancy

Collecting and analysing extensive clinical data from maternity units, to measure the effect cardiomyopathy has during pregnancy, on heart health outcomes, to better manage this condition during pregnancy going forward.

Complete
17/10/2019
South East

Data, 

Clinical trial

Awarded amount: £20,000
Grant scheme: TRP
Institution: Chelsea and Westminster Hospital
Principle Investigator: Dr Matthew Cauldwell

In the UK, cardiovascular disease is the leading indirect cause of death during pregnancy. This means that although they are not a condition that develops from the pregnancy itself, underlying heart conditions present a significant threat to a mother’s health while pregnant. Understanding how these conditions can affect health and wellbeing during pregnancy is therefore very important, ensuring that expectant mothers receive appropriate care and support.

This project, led by Dr Matthew Cauldwell, aimed to explore the impact of a specific type of heart condition, cardiomyopathy, during pregnancy. Cardiomyopathy is a disease of the heart muscle that affects its ability to successfully pump blood around the body. There are multiple different forms of cardiomyopathy, some of which stiffen the muscle, while other enlarge and weaken it.

The team collected data across all obstetric units in the UK over a three-year period about women who had an already-diagnosed cardiomyopathy during their pregnancies. Data was collected on four different types of cardiomyopathies: hypertrophic cardiomyopathy, dilated cardiomyopathy, previous peripartum cardiomyopathy, and arrhythmogenic cardiomyopathy.

In total, the data from 210 people was analysed. Their findings revealed that although no women died during their pregnancies because of their cardiomyopathy, they did require specialist care with around 1 in 20 of the women requiring admission to intensive care.

They also observed that more than 50% of women delivered their baby by caesarean section which is higher than the UK average. It was unclear from the data the reasoning for each of these c-sections, however this does indicate a higher level of intervention was required for these women. Additionally, a significant proportion of the babies were born before 37 weeks, which meant 1 in 5 of them required care in a neonatal intensive care unit (NICU). This highlights that there is the potential for higher risk of complications for women with underlying cardiomyopathy, and their babies.

National guidance around managing underlying heart conditions during pregnancy recommends that all women should have access to specialist counselling when planning a pregnancy. This is designed to ensure that women understand their condition and the potential risks that it presents during their pregnancy. However, the data revealed that only around 50% of women had evidence of having clear preconception counselling.

Overall, the data collected in this study shows that women with cardiomyopathy generally have good outcomes during pregnancy, but there are some potential increased risks, particularly in terms of pre-term birth and resulting admission for babies into the ICU. This highlights the need for women to have access to pre-pregnancy counselling to best understand their condition and the potential impact on any pregnancy they may have.

The team hope that these findings will encourage doctors to engage in providing this specialised support to women with cardiomyopathy, and they hope to continue their work exploring the long-term outcomes for pregnant women with underlying heart conditions.

Apply for a Research Grant

Learn more

More Research Projects

3D heart modelling for personalised ablation

The development of a new AI-supported model for imaging the heart based on data from over 700 people with atrial fibrillation, allow ablation to be more personalised to individual patients.

In progress
19/06/2025
Read more

A new, low-cost test for heart failure

Developing a new, low-cost blood test to diagnose heart failure earlier, outside of hospital, and in the community, enabling patients to receive more personalised care, reducing costs and hospital admissions.

In progress
10/07/2026
Read more

A trial for every patient

Bringing together patients and medical professionals to establish a partnership aimed at identifying areas of priority in adult cardiac surgery, to better inform clinicians and make heart surgery safer for patients.

In progress
13/03/2024
Read more

AI assisted pacing

Developing an AI-assisted computer programme to identify whether a conduction system pacing (CSP) procedure has been successful, which will allow more patients to benefit from this innovative pacemaker technology.

In progress
25/11/2024
Read more
All Medical Research Projects

Donate to Research

Your gifts fund our life saving project

Give to Research